Thermo Fisher Scientific Inc. (TMO)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-07-23) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-04-23) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-01-29) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-10-22) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-07-23) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-04-23) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-01-30) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-10-23) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-07-24) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-04-24) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-01-31) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-10-25) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Income | ||
| Consolidated Statements of Comprehensive Income | ||
| Consolidated Statements of Comprehensive Income (P) | ||
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Redeemable Noncontrolling Interest and Equity | ||
| Consolidated Statements of Redeemable Noncontrolling Interest and Equity (P) | ||
| Notes | ||
| Acquisitions | ||
| Acquisitions and Divestiture | — |
|
| Business Segment and Geographical Information | ||
| Business Segment Information | — |
|
| Commitments and Contingencies | ||
| Comprehensive Income and Shareholders Equity | — |
|
| Comprehensive Income/(loss) | — |
|
| Comprehensive Income/(loss) and Shareholders' Equity | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt and Other Financing Arrangements | ||
| Derivatives | ||
| Earnings Per Share | ||
| Fair Value Measurements | ||
| Fair Value Measurements and Fair Value of Financial Instruments | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases | — |
|
| Nature of Operations and Summary of Significant Accounting Policies | ||
| Other Income/expense | — |
|
| Pay Vs Performance Disclosure | — |
|
| Pension and Other Postretirement Benefit Plans | — |
|
| Restructuring and Other Costs | ||
| Revenue and Contract-related Balances | ||
| Stock-based Compensation Expense | — |
|
| Supplemental Balance Sheet Information | ||
| Supplemental Cash Flow Information | ||
| Supplemental Income Statement Information | ||